Exantas Capital Corp. (NYSE:XAN) has a beta value of 1.45 and has seen 762,827 shares traded in the last trading session. The company, currently valued at $103.98 Million, closed the last trade at $3.24 per share which meant it gained $0.18 on the day or 5.88% during that session. The XAN stock price is -286.11% off its 52-week high price of $12.51 and 70.68% above the 52-week low of $0.95. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.18 Million shares traded. The 3-month trading volume is 672.75 Million shares.
The consensus among analysts is that Exantas Capital Corp. (XAN) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. None out of 2 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.07.
Exantas Capital Corp. (NYSE:XAN) trade information
Sporting 5.88% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Nov 18 when the XAN stock price touched $3.48-6 or saw a rise of 6.89%. Year-to-date, Exantas Capital Corp. shares have moved -72.57%, while the 5-day performance has seen it change 17.39%. Over the past 30 days, the shares of Exantas Capital Corp. (NYSE:XAN) have changed 62%. Short interest in the company has seen 667.38 Million shares shorted with days to cover at 0.99.
Wall Street analysts have a consensus price target for the stock at $4.25, which means that the shares’ value could jump 31.17% from current levels. The projected low price target is $4 while the price target rests at a high of $4.5. In that case, then, we find that the current price level is +38.89% off the targeted high while a plunge would see the stock lose 23.46% from current levels.
Exantas Capital Corp. (XAN) estimates and forecasts
Figures show that Exantas Capital Corp. shares have underperformed across the wider relevant industry. The company’s shares have gained +39.06% over the past 6 months, with this year growth rate of -32.71%, compared to -17.6% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -69.6% and -87% for the next quarter. Revenue growth from the last financial year stood is estimated to be -19.1%.
2 analysts offering their estimates for the company have set an average revenue estimate of $9.65 Million for the current quarter. 2 have an estimated revenue figure of $9.25 Million for the next quarter concluding in March 01, 2021. Year-ago sales stood $14.4 Million and $14.92 Million respectively for this quarter and the next, and analysts expect sales will grow by -33% for the current quarter and -38% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.6% over the past 5 years. Earnings growth for 2020 is a modest +274.1% while over the next 5 years, the company’s earnings are expected to increase by 5%.
Exantas Capital Corp. (NYSE:XAN)’s Major holders
Insiders own 3.66% of the company shares, while shares held by institutions stand at 37.56% with a share float percentage of 38.98%. Investors are also buoyed by the number of investors in a company, with Exantas Capital Corp. having a total of 77 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 1.69 Million shares worth more than $3.53 Million. As of September 29, 2020, Vanguard Group, Inc. (The) held 5.26% of shares outstanding.
The other major institutional holder is Morgan Stanley, with the holding of over 1.51 Million shares as of September 29, 2020. The firm’s total holdings are worth over $3.15 Million and represent 4.7% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Salient Select Income Fund. As of June 29, 2020, the former fund manager holds about 4.66% shares in the company for having 1497081 shares of worth $3.97 Million while later fund manager owns 810Thousand shares of worth $2.15 Million as of June 29, 2020, which makes it owner of about 2.52% of company’s outstanding stock.